GlassScriptPhysician profile
Kenneth Ryan Brooks
NPI 1093930562
$16,865.98
in general payments reported to CMS, 2019-2025
28 companies · $5,213 in 2025
The $5,213 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $678 · 2020: $993 · 2021: $1,247 · 2022: $1,566 · 2023: $2,306 · 2024: $4,862 · 2025: $5,213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,135 · Travel and Lodging: $5,247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,134.70 |
| Travel and Lodging | $5,246.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,425.07 | 2023-2025 | |
| Stryker Corporation | $3,216.49 | 2023-2025 | Mako, Triathlon, T2 Alpha |
| Medinc of Texas | $2,261.89 | 2022-2025 | |
| Depuy Synthes Products, INC. | $1,800.00 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $969.18 | 2025 | Oxford, Juggerknotless Soft Anchor |
| Depuy Synthes Sales INC. | $735.51 | 2019-2025 | Truespan Orthocord, Fms, Milagro |
| Smith+Nephew, INC. | $700.08 | 2019-2023 | Bone Anchors With Arthroscopic Delivery System, Stravix Pl |
| Linvatec Corporation | $693.08 | 2023-2025 | Biobrace 23mm |
| Miach Orthopaedics, INC. | $507.36 | 2022-2025 | |
| International Life Sciences | $499.19 | 2023 | |
| Fx Shoulder Solutions, INC | $372.50 | 2023-2024 | |
| Integrity Orthopaedics, INC. | $264.11 | 2024 | Integrity Orthopaedics |
| Rti Surgical, INC | $262.67 | 2022-2023 | |
| Anika Therapeutics, INC. | $183.54 | 2025 | Tactoset |
| Pacira Pharmaceuticals Incorporated | $155.04 | 2021-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xiros INC | $146.57 | 2024 | |
| Vericel Corporation | $117.15 | 2019-2022 | |
| Ossio INC | $113.21 | 2023 | |
| Microport Orthopedics INC | $87.86 | 2019 | |
| Catalyst Orthoscience | $83.08 | 2021 | |
| Aesculap Implant Systems, LLC | $70.81 | 2020 | |
| Carbofix Orthopedics INC | $68.82 | 2022-2025 | |
| Radius Health, INC. | $32.84 | 2021-2024 | Tymlos |
| Bioventus LLC | $30.13 | 2024 | Durolane |
| Acera Surgical, INC. | $28.19 | 2024 | Restrata Wound Matrix |
| Ethicon US, LLC | $17.01 | 2024 | Vistaseal, Ethicon |
| Eisai INC. | $13.86 | 2019 | |
| Epimed International, INC | $10.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.